|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.87 USD | -2.07% |
|
-6.48% | -46.49% |
| 06-29 | Keros Therapeutics, Inc.(NasdaqGM:KROS) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Keros Therapeutics, Inc.(NasdaqGM:KROS) added to Russell 3000E Index | CI |
| Market Cap | 220M 193M 178M 164M 311M 21.03B 317M 2.13B 834M 10.33B 825M 807M 35.66B | P/E 2026 * |
-1.85x | P/E 2027 * | -2.03x |
|---|---|---|---|---|---|
| Enterprise Value | 220M 193M 178M 164M 311M 21.03B 317M 2.13B 834M 10.33B 825M 807M 35.66B | EV / Sales 2026 * |
51.7x | EV / Sales 2027 * | 11.6x |
| Free-Float |
46.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Keros Therapeutics, Inc.
| 1 day | -2.07% | ||
| 1 week | -6.48% | ||
| Current month | +1.82% | ||
| 1 month | +6.40% | ||
| 3 months | -5.67% | ||
| 6 months | -44.21% | ||
| Current year | -46.49% |
| 1 week | 10.74 |  | 12.18 |
| 1 month | 9.98 | | 12.18 |
| Current year | 9.69 | | 20.34 |
| 1 year | 9.69 | | 22.55 |
| 3 years | 9.12 | | 73 |
| 5 years | 9.12 | | 73 |
| 10 years | 9.12 | | 88.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 70 | 30/11/2015 |
Keith Regnante
DFI | Director of Finance/CFO | 56 | 31/01/2020 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jasbir Seehra
CHM | Chairman | 70 | 30/06/2024 |
Julius Knowles
BRD | Director/Board Member | 63 | 31/03/2016 |
Nima Farzan
BRD | Director/Board Member | 50 | 29/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Free | Director | 28,656 | 0.1448% | ||
| 06-14 | Buy | Chairman | 1,000 | 0.0051% | ||
| 06-10 | Sell | Director | -550 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.07% | -6.48% | -25.22% | -73.20% | 220M | |
| -2.48% | -2.22% | +55.85% | +79.12% | 53.54B | |
| -0.26% | -6.72% | +55.44% | +126.83% | 54.18B | |
| -0.67% | -4.71% | +5.54% | +421.99% | 23.66B | |
| +0.07% | -4.48% | -18.86% | -16.79% | 22.78B | |
| +2.36% | +1.06% | +43.34% | -6.14% | 19.54B | |
| -2.05% | -1.74% | +35.82% | -29.01% | 17.82B | |
| -4.00% | -7.88% | +175.60% | +343.60% | 16.01B | |
| -1.15% | -4.83% | +46.53% | +627.30% | 15.37B | |
| -0.91% | -2.76% | +21.77% | +186.26% | 14.09B | |
| Average | -1.14% | -2.14% | +39.58% | +166.00% | 23.72B | |
| Weighted average by Cap. | -1.06% | -2.46% | +46.41% | +159.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.25M 3.73M 3.45M 3.18M 6.01M 407M 6.13M 41.17M 16.15M 200M 15.97M 15.62M 690M | 18.91M 16.59M 15.36M 14.13M 26.74M 1.81B 27.26M 183M 71.81M 889M 71.01M 69.46M 3.07B |
| Net income | -120M -106M -97.85M -90.04M -170M -11.53B -174M -1.17B -457M -5.66B -452M -442M -19.55B | -132M -116M -107M -98.65M -187M -12.63B -190M -1.28B -501M -6.2B -496M -485M -21.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | US$10.90 | -1.85% | 28,941 |
| 13/07/26 | US$11.10 | -5.93% | 251,059 |
| 10/07/26 | US$11.80 | -1.91% | 259,092 |
| 09/07/26 | US$12.03 | +3.08% | 371,362 |
| 08/07/26 | US$11.67 | +0.17% | 302,617 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KROS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
